Search results

Articles (4)

Journals (0)

1-4 of 4 results for glatiramoids

Sort by:

Relevance

Select all

Sort by:

Relevance

Free accessResearch articleFirst published January, 2012

Comparative Long-Term Preclinical Safety Evaluation of Two Glatiramoid Compounds (Glatiramer Acetate,Copaxone®,and TV-5010,Protiramer) in Rats and Monkeys

Yuval Ramot, Moti Rosenstock, Ety Klinger [...]

Toxicologic Pathology

Open accessCase reportFirst published 2021

Lymphomatoid papulosis in a patient treated with glatiramer acetate and the glatiramoid Glatopa for multiple sclerosis: A case report

Afsaneh Shirani, Scott R Dalton, Eric J Avery [...]

Journal of Central Nervous System Disease

Restricted accessResearch articleFirst published March, 2012

Complex Drugs and Biologics: Scientific and Regulatory Challenges for Follow-on Products

J. Michael Nicholas

Therapeutic Innovation & Regulatory Science

Restricted accessResearch articleFirst published February, 2009

The results of two multicenter,open-label studies assessing efficacy,tolerability and safety of protiramer,a high molecular weight synthetic copolymeric mixture,in patients with relapsing–remitting multiple sclerosis

N De Stefano, M Filippi, C Confavreux [...]

Multiple Sclerosis Journal

Search results

Articles (4)

Journals (0)

1-4 of 4 results for glatiramoids

Sort by:

Relevance

Select all

Sort by:

Relevance

Free accessResearch articleFirst published January, 2012

Comparative Long-Term Preclinical Safety Evaluation of Two Glatiramoid Compounds (Glatiramer Acetate,Copaxone®,and TV-5010,Protiramer) in Rats and Monkeys

Yuval Ramot, Moti Rosenstock, Ety Klinger [...]

Toxicologic Pathology

Open accessCase reportFirst published 2021

Lymphomatoid papulosis in a patient treated with glatiramer acetate and the glatiramoid Glatopa for multiple sclerosis: A case report

Afsaneh Shirani, Scott R Dalton, Eric J Avery [...]

Journal of Central Nervous System Disease

Restricted accessResearch articleFirst published March, 2012

Complex Drugs and Biologics: Scientific and Regulatory Challenges for Follow-on Products

J. Michael Nicholas

Therapeutic Innovation & Regulatory Science

Restricted accessResearch articleFirst published February, 2009

The results of two multicenter,open-label studies assessing efficacy,tolerability and safety of protiramer,a high molecular weight synthetic copolymeric mixture,in patients with relapsing–remitting multiple sclerosis

N De Stefano, M Filippi, C Confavreux [...]

Multiple Sclerosis Journal